Author details

Full Name

Jolanta Bondaruk

Affiliation

The University of Texas MD Anderson Cancer Center

ORCID

Career Start Year

1985

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
34789422	Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer.	Eur Urol Oncol	2023
35811851	Erratum: The origin of bladder cancer from mucosal field effects.	iScience	2022
32521509	Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer.	iScience	2020
32546765	Assessment of Luminal and Basal Phenotypes in Bladder Cancer.	Sci Rep	2020
29428551	Detection of Bladder Cancer in Urine Sediments by a Novel Multicolor Fluorescence In Situ Hybridization (Quartet) Test.	Eur Urol Focus	2019
31582354	Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort study.	Lancet Oncol	2019
30784602	Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder Carcinogenesis.	Cell Rep	2019
28827100	Carcinoma of the urethra.	Hum Pathol	2018
28102366	Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior.	Sci Rep	2017
26953815	In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type.	Cancer	2016
27612592	Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use.	EBioMedicine	2016
27713144	RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulation.	Oncotarget	2016
27148669	Addendum to Bell et al's "In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type".	Cancer	2016
27495099	Comparison between whole mount tissue preparations and virtual tissue microarray samples for measuring Ki-67 and apoptosis indices in human bladder cancer: A cross-sectional study.	Medicine (Baltimore)	2016
26988609	Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer.	Eur Urol	2016
24525232	Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.	Cancer Cell	2014
23657946	Fibroblast growth factor receptor 3 is a rational therapeutic target in bladder cancer.	Mol Cancer Ther	2013
24121789	Frequent truncating mutations of STAG2 in bladder cancer.	Nat Genet	2013
22441703	Low molecular weight cyclin E is associated with p27-resistant, high-grade, high-stage and invasive bladder cancer.	Cell Cycle	2012
22879988	Detection of bladder cancer using proteomic profiling of urine sediments.	PLoS One	2012
21586619	Detection of bladder cancer using novel DNA methylation biomarkers in urine sediments.	Cancer Epidemiol Biomarkers Prev	2011
21078438	Expression of master regulatory genes controlling skeletal development in benign cartilage and bone forming tumors.	Hum Pathol	2010
19454359	Squamous cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 16 cases.	Hum Pathol	2009
18006009	Distinctive expression pattern of ErbB family receptors signifies an aggressive variant of bladder cancer.	J Urol	2008
18812553	Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.	J Natl Cancer Inst	2008
18458673	Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy.	Lab Invest	2008
17702869	Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasia.	Proc Natl Acad Sci U S A	2007
16899617	Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy.	Clin Cancer Res	2006
15778693	Alterations in transcription clusters underlie development of bladder cancer along papillary and nonpapillary pathways.	Lab Invest	2005
14702041	Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53.	Nat Genet	2004
15390184	Specific chromosome aberrations in peripheral blood lymphocytes are associated with risk of bladder cancer.	Genes Chromosomes Cancer	2004
14973053	Molecular detection of noninvasive and invasive bladder tumor tissues and exfoliated cells by aberrant promoter methylation of laminin-5 encoding genes.	Cancer Res	2004
2707971	Synthesis and biological evaluation of human preproenkephalin (100-111) and its analogs.	Int J Pept Protein Res	1989
4076048	The effect of Met-enkephalin and its analogues on gonadotrophin release in patients with polycystic ovary syndrome.	Endokrynol Pol	1985

1 - 34 of 34

Stephanie A Wankowicz

University of California San Francisco

Career Start Year 2014

Number of shared co-authors 2

Andrew Goodspeed

University of Colorado Denver | Anschutz Medical Campus

Career Start Year 2013

Number of shared co-authors 0

Jacqueline Fontugne

Institut Curie, CNRS, PSL Research University

Career Start Year 2013

Number of shared co-authors 6

Ekaterina Olkhov-Mitsel

University of Toronto

Career Start Year 2012

Number of shared co-authors 0

Cynthia Kuk

Mount Sinai Hospital, University of Toronto, University Health Network

Career Start Year 2007

Number of shared co-authors 0

Bishoy M Faltas

Sandra and Edward Meyer Cancer Center

Career Start Year 2007

Number of shared co-authors 4

Song Wu

The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group)

Career Start Year 2006

Number of shared co-authors 0

Jonathan Chou

University of California san francisco

Career Start Year 2005

Number of shared co-authors 0

Robert H Bell

University of British Columbia

Career Start Year 2004

Number of shared co-authors 3

Amy G Robertson

Present address: Dxige Research Inc.

Career Start Year 2003

Number of shared co-authors 10

Michiel S van der Heijden

the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital

Career Start Year 2002

Number of shared co-authors 3

H??l??ne Hovington

Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)

Career Start Year 1999

Number of shared co-authors 0

Ronald Simon

Institute of Pathology, University Medical Center Hamburg-Eppendorf

Career Start Year 1996

Number of shared co-authors 3

Feliksas Jankevicius

Clinic of Gastroenterology, Vilnius University

Career Start Year 1995

Number of shared co-authors 1

Louis Lacombe

CHU de Quebec-Universite Laval

Career Start Year 1994

Number of shared co-authors 0

Ganesh V Raj

University of Texas Southwestern Medical Center at Dallas

Career Start Year 1994

Number of shared co-authors 1

Arul M Chinnaiyan

University of Michigan Medical School.

Career Start Year 1993

Number of shared co-authors 5

Holger Moch

University Hospital Zurich

Career Start Year 1991

Number of shared co-authors 3

Guido Sauter

Institute of Pathology, University Medical Center Hamburg-Eppendorf

Career Start Year 1990

Number of shared co-authors 6

Alain Bergeron

Centre de recherche sur le cancer de l'Universite Laval

Career Start Year 1990

Number of shared co-authors 0

Sonata Jarmalaite

Institute of Biosciences, Vilnius University

Career Start Year 1989

Number of shared co-authors 0

Christopher M Hovens

Royal Melbourne Hospital, The University of Melbourne

Career Start Year 1989

Number of shared co-authors 0

Bernd Wullich

University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)

Career Start Year 1989

Number of shared co-authors 0

Luigi Marchionni

Weill-Cornell School of Medicine

Career Start Year 1989

Number of shared co-authors 3

Adrie van Bokhoven

University of Colorado Anschutz Medical Campus

Career Start Year 1988

Number of shared co-authors 0

Victor E Reuter

Memorial Sloan Kettering Cancer Center

Career Start Year 1983

Number of shared co-authors 11

Francisco X Real

Spanish National Cancer Research Centre-CNIO

Career Start Year 1983

Number of shared co-authors 5

David M Berman

Queen's University

Career Start Year 1982

Number of shared co-authors 0

Yves Fradet

CHU de Quebec-Universite Laval

Career Start Year 1975

Number of shared co-authors 6

Jeffrey S Ross

Foundation Medicine

Career Start Year 1974

Number of shared co-authors 7

row(s) 1 - 30 of 30

Bogdan Czerniak

University of Texas MD Anderson Cancer Center

Co-authored papers 30

Colin P Dinney

The University of Texas MD Anderson Cancer Center

Co-authored papers 18

David J McConkey

Johns Hopkins School of Medicine

Co-authored papers 13

Keith A Baggerly

The University of Texas MD Anderson Cancer Center

Co-authored papers 12

Herbert Barton Grossman

University of Texas MD Anderson Cancer Center

Co-authored papers 9

David Cogdell

The University of Texas MD Anderson Cancer Center

Co-authored papers 6

John N Weinstein

The University of Texas MD Anderson Cancer Center

Co-authored papers 6

Menashe Bar-Eli

The University of Texas MD Anderson Cancer Center

Co-authored papers 5

Philippe E Spiess

H. Lee Moffitt Cancer Center and Research Institute

Co-authored papers 4

Jean-Pierre J Issa

Fels Cancer Institute for Personalized Medicine, Temple University School of Medicine

Co-authored papers 4

Steven E Scherer

Baylor College of Medicine

Co-authored papers 3

Liana Adam

The University of Texas MD Anderson Cancer Center

Co-authored papers 2

Subrata Sen

UT MD Anderson Cancer Center

Co-authored papers 2

John D Minna

University of Texas Southwestern Medical Center at Dallas

Co-authored papers 1

Shaolong Cao

the University of Texas MD Anderson Cancer Center

Co-authored papers 1

Melanie Dujka

University of Texas MD Anderson Cancer Center

Co-authored papers 1

Kenneth Aldape

National Cancer Institute

Co-authored papers 1

Abdel G Elkahloun

National Human Genome Research Institute

Co-authored papers 1

Markku Miettinen

National Cancer Institute

Co-authored papers 1

Shoudan Liang

The University of Texas MD Anderson Cancer Center

Co-authored papers 1

Yi-Jue Zhao

The First Affiliated Hospital of Guangxi Medical University

Co-authored papers 1

Gregory N Fuller

MD Anderson Cancer Center

Co-authored papers 1

Mark A Rubin

University of Bern

Co-authored papers 1

Oliver B??gler

American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University

Co-authored papers 1

Linghua Wang

The University of Texas M. D. Anderson

Co-authored papers 1

Wei Zhang

The University of Texas MD Anderson Cancer Center

Co-authored papers 1

Charles D James

Co-authored papers 1

Kenna R Mills Shaw

The University of Texas MD Anderson Cancer Center

Co-authored papers 1